0.2169
price up icon5.60%   0.0115
after-market Handel nachbörslich: .21 -0.0069 -3.18%
loading

Finanzdaten der Processa Pharmaceuticals Inc-Aktie (PCSA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Income/Loss
13.77%
-2.8096
-2.4695 -2.1676 -2.7145 -4.1055
Income/Loss From Continuing Operations Before Tax
13.37%
-2.7264
-2.4049 -2.082 -2.6126 -4.0221
Income/Loss From Continuing Operations After Tax
13.37%
-2.7264
-2.4049 -2.082 -2.6126 -4.0221
Net Income/Loss
13.37%
-2.7264
-2.4049 -2.082 -2.6126 -4.0221
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
110.16%
2.4665
-24.27 27.00 26.94 22.77
Diluted Average Shares
110.16%
2.4665
-24.27 27.00 26.94 -2.0708
Basic Earnings Per Share
86.36%
-1.11
-8.14 -0.08 -0.10 -0.18
Diluted Earnings Per Share
86.36%
-1.11
-8.14 -0.08 -0.10 -0.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.87
price up icon 3.40%
$35.60
price down icon 2.49%
$104.59
price up icon 1.67%
$28.27
price up icon 16.05%
$112.49
price up icon 1.66%
biotechnology ONC
$279.16
price up icon 3.51%
Kapitalisierung:     |  Volumen (24h):